Diagnosis and Treatment of Head and Neck Sarcomas: Personal Experiences
Journal of Cancer Treatment and Research
Volume 1, Issue 1, July 2013, Pages: 1-7
Received: Jun. 25, 2013; Published: Jul. 20, 2013
Views 3792      Downloads 211
Authors
Melissa Laus, ENT Department, University “G. D’Annunzio” of Chieti-Pescara, Hospital “SS. Annunziata”, Via dei Vestini, 66100 Chieti, Italy
Domenico Crescenzi, ENT Department, University “G. D’Annunzio” of Chieti-Pescara, Hospital “SS. Annunziata”, Via dei Vestini, 66100 Chieti, Italy
Antonio Moretti, ENT Department, University “G. D’Annunzio” of Chieti-Pescara, Hospital “SS. Annunziata”, Via dei Vestini, 66100 Chieti, Italy
Adelchi Croce, ENT Department, University “G. D’Annunzio” of Chieti-Pescara, Hospital “SS. Annunziata”, Via dei Vestini, 66100 Chieti, Italy
Article Tools
PDF
Follow on us
Abstract
Sarcomas are a rare group of tumors. They do not commonly manifest as malignancies in the head and neck region. The rare nature of these tumors has resulted in a limited number of publications. This is a descriptive study. We included patients with primary sarcomas of the head and neck, observed between 1991 and 2011 in the department of Otorhinolaryngology (University of Chieti, Italy). We studied the following variables: age, gender, race, origin, primary anatomical location of the neoplasm, pathology, diagnosis and type of cancer treatment employed. During the study period, we found 9 patients with head and neck sarcomas. Of this sample, 6 were males, and 3 were females. The man/woman ratio was 2:1. As far as age is concerned, the most affected age range was between 60 and 80 years. The mean age of the patients was 62. As far as pathology is concerned, we found 7 histopathological variations of sarcomas, and the most common type was the leiomyosarcoma. The most widely used treatment modality was surgical treatment. The data in this study show that head and neck sarcomas are rare tumors with high histological variability, which may involve different anatomical sites. Since these are rare and not well-known lesions, further epidemiological studies must be carried out, in order to give us more knowledge about the disease.
Keywords
Sarcoma, Head and Neck, Multivariate Analysis, Treatment Outcomes
To cite this article
Melissa Laus, Domenico Crescenzi, Antonio Moretti, Adelchi Croce, Diagnosis and Treatment of Head and Neck Sarcomas: Personal Experiences, Journal of Cancer Treatment and Research. Vol. 1, No. 1, 2013, pp. 1-7. doi: 10.11648/j.jctr.20130101.11
References
[1]
Adisa AO, Adeyemi BF, Oluwasola AO, Kolude B, Akang EEU, Lawoyin JO, "Clinico pathological profile of head and neck malignancies at University College Hospital, Ibadan, Nigeria," Head & Face Medicine, vol. 7, pp. 1-9, 2011.
[2]
McMains CK, Gourin CG, "Pathology: Sarcomas of the head and neck," Emedicine, 2007.
[3]
Wanebo HJ, Koness RJ, MacFarlane JK, "Head and neck sarcoma: report of the Head and Neck Sarcoma Registry. Society of Head and Neck Surgeons Committee on Research," Head and Neck, vol. 14, pp. 1-7, 1992.
[4]
Potter BO, Sturgis EM, "Sarcomas of the head and neck," Surg Oncol Clin N Am, vol. 12, pp. 379-417, 2003.
[5]
Mendenhall WM, Mendenhall CM, Werning JW,Riggs CE, Mendenhall NP, "Adult head and neck sof tissue sarcomas," Head & Neck, vol. 27(10), pp. 916-922, 2005.
[6]
Barnes L, Eveson J, Reichart P, "World Health Organization classification of tumours," Pathology and genetics of tumours of the head and neck Lyon: IARC Press, 2005.
[7]
Rapidis AD, "Sarcomas of the head and neck in adult patients: current concepts and future perspectives," Expert Rev. Anticancer Ther, vol. 8(8), pp. 1271-1297, 2008.
[8]
Sturgis EM, Potter BO, "Sarcomas of the head and neck region," Curr Opin Oncol, vol. 15(3), pp. 239-252, 2003.
[9]
Singh RP, Grimer RJ, Bhujel N, Carter SR, Tillman RM, Abudu A, "Adult Head and Neck Soft Tissue Sarcomas:Treatment and Outcome," Hindawi Publishing Corporation Sarcoma, pp. 1-5, 2008.
[10]
Huber GF, Matthews TW, Dort JC, "Soft-tissue sarcomas of the head and neck: a retrospective analysis of the Alberta experience 1974 to 1999," Laryngoscope, vol. 116( 5), pp. 780–785, 2006.
[11]
Chen SA, Morris CG, Amdur RJ, Werning JW, VillaretDB, Mendenhall WM, "Adult head and neck soft tissue sarcomas," American Journal of Clinical Oncology, vol. 28(3), pp. 259–263, 2005.
[12]
Eeles RA, Fisher C, A’Hern RP, "Head and neck sarcomas: prognostic factors and implications for treatment," British Journal of Cancer, vol. 68(1), pp. 201–207, 1993.
[13]
Farhood AI, Hajdu SI, Shiu MH, Strong EW, "Soft tissue sarcomas of the head and neck in adults," The American Journal of Surgery, vol. 160(4), pp. 365–369, 1990.
[14]
Huber GF, Matthews TW, Dort JC, "Soft-tissue sarcomas of the head and neck: a retrospective analysis of the Alberta experience 1974 to 1999," Laryngoscope, vol. 116(5), pp. 780-785, 2006.
[15]
Schenberg ME, Slootweg PJ, Koole R, "Leiomyosarcomas of the oral cavity. Report of four cases and review of the literature," J Craniomaxillofac Surg, vol. 21(8), pp. 342-347, 1993.
[16]
Barnes L, Kanbour A, "Malignant fibrous histiocytoma of the head and neck. A report of 12 cases," Arch Otolaryngol Head Neck Surg, vol. 114(10), pp. 1149-1156, 1988.
[17]
Vilos GA, Rapidis AD, Lagogiannis GD, Apostolidis C, "Leiomyosarcomas of the oral tissues: clinicopathologic analysis of 50 cases," J Oral Maxillofac Surg, vol. 63(10), pp. 1461-1477, 2005.
[18]
Estilo CL, Huryn JM, Kraus DH, "Effects of therapyvon dentofacial development in long-term survivors of head and neck rhabdomyosarcoma: the memorial sloan-kettering cancer center experience," J Pediatr Hematol Oncol, vol. 25(3), pp. 215-222, 2003.
[19]
Callender TA, Weber RS, Janjan N, "Rhabdomyosarcoma of the nose and paranasal sinuses in adults and children," Otolaryngol Head Neck Surg, vol. 112, pp. 252-7, 1995.
[20]
el-Naggar AK, Batsakis JG, Ordonez NG, "Rhabdomyosarcoma of the adult head and neck: a clinicopathological and DNA ploidy study," J Laryngol Otol, vol. 107, pp. 716-20, 1993.
[21]
Nayar RC, Prudhomme F, Parise O Jr, "Rhabdomyosarcoma of the head and neck in adults: a study of 26 patients," Laryngoscope, vol. 103, pp. 1362-6, 1993.
[22]
Hosoi H, Teramukai S, Matsumoto Y, "A review of 331 rhabdomyosarcoma cases in patients treated between 1991 and 2002 in japan," Int J Clin Oncol, vol. 12(2), pp. 137-145, 2007.
[23]
La Quaglia MP, Heller G, Ghavimi F, The effect of age at diagnosis on out come in rhabdomyosarcoma, Cancer, vol. 73, pp. 109-17, 1994.
[24]
Frankenthaler R, Ayala AG, Hartwich RW. Fibrosarcoma of the head and neck. Laryngoscope 1990: 100; 799-802.
[25]
Mark RJ, Sercarz JA, Tran L, "Fibrosarcoma of the head and neck: the UCLA experience," Arch Otolaryngol Head Neck Surg, vol. 117, pp. 396-401, 1991.
[26]
Greager JA, Reichard K, Campana JP, "Fibrosarcoma of the head and neck," Am J Surg, vol. 167, pp. 437-9, 1994.
[27]
Jay A, Piper K, Farthing PM, Carter J, Diwakar A, "Low-grade myofibroblastic sarcoma of the tongue," Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod, vol. 104(5), pp. e52-e58, 2007.
[28]
Jameson CF, Simpson MT, Towers JF, "Primary epithelioid sarcoma of the hard palate. A case report," Int J Oral Maxillofac Surg, vol. 19(4), pp. 240-242, 1990.
[29]
Ramirez-Amador V, Martinez-Mata G, Gonzalez-Ramirez I, Anaya-Saavedra G, de Almeida OP, "Clinical, histological and immunohistochemical findings in oral Kaposi’s sarcoma in a series of Mexican AIDS patients. Comparative study," J Oral Pathol Med, vol. 38(4), pp. 328-33, 2009.
[30]
Feller L, Wood NH, Lemmer J, "HIV-associated Kaposi sarcoma: pathogenic mechanisms," Oral Surg Oral Med Oral Pathol Oral Radiol Endod, vol. 104(4), pp. 521-9, 2007.
[31]
Schwartz RA, Micali G, Nasca MR, Scuderi L, "Kaposi sarcoma: a continuino conundrum," J Am Acad Dermatol, vol. 59(2), pp. 179-206, 2008.
[32]
Szajerka T, Jablecki J, "Kaposi’s sarcoma revisited," AIDS Rev, vol. 9(4), pp. 230-6, 2007.
[33]
Lanternier F, Lebbè C, Schartz N, Farhi D, Marcelin AG, Kèrob D, "Kaposi’s sarcoma in HIV-negative men having sex with men," AIDS, vol. 22(10), pp. 1163-8, 2008.
[34]
Sissolak G, Mayaud P, "AIDS-related Kaposi’s sarcoma: epidemiological, diagnostic, treatment and control aspects in sub-Saharan Africa," Trop Med Int Health, vol. 10(10), pp. 981-92, 2005.
[35]
Schwartz RA, "Kaposi’s sarcoma: an update," J Surg Oncol, vol. 87(3), pp. 146-51, 2004.
[36]
Iscovich J, Boffetta P, Franceschi S, Azizi E, Sarid R, "Classic kaposi sarcoms: epidemiology and risk factors. Cancer 200AIDS registry linkage study. Classic Kaposi’s sarcoma in Italy, 1985-1998," Br J Cancer, vol. 92(1), pp. 188-93, 2005.
[37]
Mohanna S, Bravo F, Ferrufino JC, Sanchez J, Gotuzzo E, "Classic Kaposi’s sarcoma presenting in the oral cavity of two HIV-negative Quechua patients," Med Oral Patol Oral Cir Bucal, vol. 12(5), pp. E365-368, 2007.
[38]
Patrikidou A, Vahtsevanos K, Charalambidou M, Valeri RM, Xirou P, Antoniades K, "Kaposi’s sarcoma in the head and neck area," Head Neck, vol. 31(2), pp. 260-8, 2009.
[39]
Pagani D, Bellinvia M, Capaccio P, Scoppio Brambilla L, Pignataro L, "An unusual cause of a parotid mass in an immunocompetent host: classic Kaposi’s sarcoma," Tumori, vol. 95(2), pp. 248-50, 2009.
[40]
Cottoni F, Masala MV, Piras P, Montesu MA, Cerimele D, "Mucosal involvement in classic Kaposi’s sarcoma," Br J Dermatol, vol. 148(6), pp. 1273-4, 2003.
[41]
Reis-Filho JS, Souto-Moura C, Lopes JM, "Classic Kaposi’s sarcoma of the tongue: case report with emphasis on the differential diagnosis," J Oral Maxillofac Surg, vol. 60(8), pp. 951-4, 2002.
[42]
Puxeddu R, Parodo G, Locci F, Puxeddu I, Manconi PE, Ferreli C, "Parotid mass as an early sign of Kaposi’s sarcoma associated with human herpesvirus 8 infection," J Laryngol Otol, vol. 116(6), pp. 470-3, 2002.
[43]
Hajdu SI, "Peripheral nerve sheath tumors. Histogenesis, classification, and prognosis," Cancer, vol. 72(12), pp. 3549-3552, 1993.
[44]
Wanebo HJ, Koness RJ, MacFarlane JK, "Head and neck sarcoma: report of the Head and Neck Sarcoma Registry. Society of Head and Neck Surgeons Committee on Research," Head Neck, vol. 14, pp. 1-7, 1992.
[45]
Lawrence W Jr, "Operative management of soft tissue sarcomas: impact of anatomic site," Semin Surg Oncol, vol. 10, pp. 340-6, 1994.
[46]
Weber RS, Benjamin RS, Peters LJ, "Soft tissue sarcomas of the head and neck in adolescents and adults," Am J Surg, vol. 152, pp. 386-92, 1986.
[47]
Laskin WB, "Dermatofibrosarcoma protuberans," CA Cancer J Clin, vol. 42, pp. 116-25, 1992.
[48]
Kraus DH, "Sarcomas of the Head and Neck," Current Oncology Reports, vol. 4, pp. 68-75, 2002.
[49]
American Joint Committee on Cancer, "Soft tissue sarcoma," in Greene FL, Editor. AJCC cancer staging manual, 6thed, New York, Spanier SS, 2002, pp. 193-200.
[50]
Parsons JT, Zlotecki RA, Reddy KA, Mitchell TP, Marcus Jr. RB, Scarborough MT, "The role of radiotherapy and limb-conserving surgery in the management of soft-tissue sarcomas in adults," Hematology/Oncology Clinics of North America, vol. 15( 2), pp. 377–388, 2001.
[51]
O’Sullivan B, Gullane P, Irish J, "Preoperative radiotherapy for adult head and neck soft tissue sarcoma: assessment of wound complication rates and cancer outcome in a prospective series," World Journal of Surgery, vol. 27( 7), pp. 875–883, 2003.
[52]
Bree R, Valk PVD, Kuik DJ, Doornaert P, Buter J, "Prognostic factors in adult soft tissue sarcomas of the head and neck: a single-centre experience," Oral Oncol, vol. 42, pp. 703-9, 2006.
[53]
Gorsky M, Epstein JB, "Head and neck and intra-oral soft tissue sarcomas," Oral Oncol, vol. 34, pp. 292-6, 1998.
[54]
Yamaguchi S, Nagasawa H, Suzuki T, Fujii E, Iwaki H, Takagi M, Amagasa T, "Sarcomas of the oral and maxillofacial region: a review of 32 cases in 25 years," Clin Oral Invest, vol. 8, pp. 52-5, 2004.
[55]
Tran LM, Mark R, Meier R, Calcaterra TC, Parker RG, "Sarcomas of the head and neck. Prognostic factors and treatment strategies," Cancer, vol. 70, pp. 169-77, 1992.
[56]
Nasri S, Mark RJ, Sercarz JA, Tran LM, Sadeghi S, "Pediatric sarcomas of the head and neck other than rhabdomyosarcoma," Am J Otolaryngol, vol. 3, pp. 165-71, 1995.
[57]
Lajer CB, Daugaard S, Hansen HS, Kirkegaard J, Holmgaard S, Christensen ME, "Soft tissue sarcomas of the head and neck: a single-centre experience," Clin Otolaryngol, vol. 30, pp. 176-82, 2005.
[58]
Penel N, Van Haverbeke C, Lartigau E, Vilain MO, Ton Van J, Mallet Y, "Head and neck soft tissue sarcoma of adult: prognostic value of surgery in multimodal therapeutic approach," Oral Oncol, vol. 40, pp. 890-7, 2004.
[59]
Gorsky M, Epstein JB, "Craniofacial osseous and chondromatous sarcomas in British Columbia – a review of 34 cases," Oral Oncol, vol. 36, pp. 27-31, 2000.
[60]
Le QT, Fu KK, Kroll S, Fitts L, Massullo V, Ferrell L, "Prognostic factors in adult soft tissue sarcoma of the head and neck," Int J Radiat Oncol Biol Phys, vol. 37, pp. 975-84, 1997.
[61]
Dijkstra MD, Balm AJM, Coevorden FV, Gregor RT, Hart AA, Hilgers FJ, "Survival of adult patients with head and neck soft tissue sarcomas," Clin Otolaryngol, vol. 21, pp. 66-71, 1996.
[62]
Dudhat SB, Mistry RC, Varughese T, Fakih AR, Chinoy RF, "Prognostic factors in head and neck soft tissue sarcomas," Cancer, vol. 89, pp. 868-72, 2000.
[63]
Kraus DH, Dubner S, Harrison LB, "Prognostic factors for recurrence and survival in head and neck soft tissue sarcomas," Cancer, vol. 74, pp. 697-702, 1994.
[64]
Bentz BG, Singh B, Woodruff J, Brennan M, Shah JP, Kraus D, "Head and neck soft tissue sarcoma: a multivariate analysis of outcome," Ann Surg Oncol, vol. 11, pp. 619-28, 2005.
[65]
Pacheco IA, Alves APNN, Mota MRL, de Almeida PC, Holanda ME, de Souza EF, Sousa FB, "Clinicopathological study of patients with head and neck sarcomas," Braz J Otorhinolaryngol, vol. 77(3), pp. 385-90, 2011.
[66]
Wax MK, "Adult head and neck soft tissue sarcomas," Head & Neck, pp. 916-22, 2005.
[67]
Balm AJ, Vom Coevorden F, Bos KE, "Report of a symposium on diagnosis and treatment of adult soft tissue sarcomas in the head and neck," Eur J Surg Oncol, vol. 21, pp. 287-289, 1995.
[68]
Blay JY, van Glabbeke M, Verweij J, "Advanced soft-tissue sarcoma: a disease that is potentially curable for a subset of patients treated with chemotherapy," Eur J Cancer, vol. 39, pp. 64-69, 2003.
[69]
van Oosterom AT, Mouridsen HT, Nielsen OS, "Results of randomized of the EORTC soft tissue and bone sarcoma group (STBSG) with two different ifosfamide regimens in first and second –line chemotherapy in advanced soft tissue sarcoma patients," Eur J Cancer, vol. 38, pp. 2397-2406, 2002.
[70]
Frustaci S, Gherlinzoni F, De Paoli A, "Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial," J Clin Oncol, vol. 19, pp. 1238-1247, 2001.
[71]
Gortzak E, Azzarelli A, Buesa J, "A randomised phase II study on neo-adjuvant chemotherapy for ‘high-risk’ adult soft-tissue sarcoma," Eur J Cancer, vol. 37, pp. 1096-1103, 2001.
[72]
Sarcoma meta-analysis collaboration, "Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data," Lancet, vol. 350, pp. 1647-1654, 1997.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186